Skip to main content
. 2020 Jan 8;28(9):4373–4380. doi: 10.1007/s00520-019-05259-1

Table 2.

Demographic and clinical characteristics

Variable n (%) Median (SD)
Age 24 (100) 64.8 (± 13.8)
Gender
  Male 17 (71)
  Female 7 (29)
NSCLC sub-type
  Adenocarcinoma 2 (8)
  Squamous cell 18 (75)
  Non-differentiated 4 (17)
Cancer stage
  Stage III (locally advanced) 7 (29)
  Stage IV (metastasised) 17 (71)
    Adrenal 4
    Brain 2
    Bone 7
    Liver 2
    Lung 8
Chemotherapy received
  Yes 13 (54)
  No 10 (42)
HHS Vulnerability Disclosure